HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sally Burtles Selected Research

N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate

6/2009Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sally Burtles Research Topics

Disease

2Neoplasms (Cancer)
06/2009 - 03/2002
1Breast Cancer 3
06/2009
1Breast Neoplasms (Breast Cancer)
06/2009
1Colorectal Neoplasms (Colorectal Cancer)
06/2009
1Fatigue
03/2002
1Mucositis
03/2002
1Hepatocellular Carcinoma (Hepatoma)
03/2002
1Neutropenia
03/2002

Drug/Important Bio-Agent (IBA)

2PolymersIBA
06/2009 - 03/2002
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2009 - 03/2002
1N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugateIBA
06/2009
1AnthracyclinesIBA
06/2009
1GalactosamineIBA
03/2002

Therapy/Procedure

2Therapeutics
06/2009 - 03/2002